Haslett, K, Blackhall, F, Koh, P, Asselin, M-C, Jackson, A, Manoharan, P, Ryder, W D, Taylor, B & Faivre-Finn, C 2018, Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC . in Radiotherapy and Oncology . vol. 127, PO-0753, pp. S387-S387 . https://doi.org/10.1016/j.jtho.2017.09.620
Salem, A, Mistry, H, Backen, A, Hodgson, C, Koh, P, Dean, E, Priest, L, Haslett, K, Trigonis, I, Jackson, A, Asselin, M-C, Dive, C, Renehan, A, Faivre-Finn, C & Blackhall, F 2017, ' Cell-death, inflammation, tumor-burden and proliferation blood biomarkers predict lung cancer radiotherapy response and correlate with tumor volume and proliferation imaging ', Clinical Lung Cancer, vol. 19, no. 3, pp. 239-248 . https://doi.org/10.1016/j.cllc.2017.12.002